Dr. Evan Yu presents the new evidence-based guideline on genetic testing for metastatic prostate cancer. He discusses who should receive germline and somatic testing with next-generation sequencing ...
ASCO posted 2024 pass rates for every optometric institution in the U.S., which highlight both performance and challenges. Image: Adobe Stock According to the Association of Schools and Colleges ...
Also announced at ASCO was some intriguing new data on circulating tumour DNA (ctDNA) – fragments of genetic material from cancer cells – that can indicate the presence of minimal residual ...
Solenoid valves market was valued at US$ 4,657.6 million in 2023 and is projected to hit the market valuation of US$ 7,802.3 million by 2032 at a CAGR of 5.9% during the forecast period 2024–2032. A ...
We in the PC gaming-o-sphere tend to view Valve as a behemoth. Its iron-fisted dominance of the space is unquestioned and unchallenged, and even the mightiest of videogame publishers sooner or ...
at the upcoming American Society of Clinical Oncology Gastrointestinal Cancers (ASCO GI) Symposium. The conference will take place on January 23-25, 2025, in San Francisco, California. The ...
The big picture: Valve is one of the most important and influential companies in the PC gaming market. It's also one of the most unique due to its private nature and unusually small workforce ...
Examples include respiratory devices, orthopedic implant devices, heart valves and neurosurgical devices. The dermatological device market also has good potential, as standalone skin care and ...
Installation of an IPC is usually an ambulatory procedure and involves the insertion of a tube attached to a one-way valve into the pleural space, allowing fluid to be drained from the pleural cavity ...
Valve has played around with consoles in the past, particularly with the 'Steam Machine' technology which offers a third-party solution to transform gaming computers into a new form factor, but ...
DiveWire guarantees visibility for your news announcements through instant distribution to MedTech Dive’s audience and its 60,000 newsletter subscribers for 21 days.